Gestational diabetes mellitus: Insulinic management

Journal of Obstetrics and Gynecology of India

Volumn 64, Issue 2, 2014, Pages 82-90

  Magon, Navneet ^a   Seshiah, Veerasamy ^b  

^a Air Force Hospital   (India)

^b Dr Balaji Diabetes Care Centre   (India)

Author keywords

Aspart; Detemir; Diabetes; GDM; Insulin; Lispro; Pregnancy

Indexed keywords

BIPHASIC INSULIN; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; PIG INSULIN; PREMIXED INSULIN; RECOMBINANT HUMAN INSULIN; SHORT ACTING INSULIN; UNCLASSIFIED DRUG;

ANTENATAL INSULIN TREATMENT; BLOOD GLUCOSE MONITORING; DIABETIC DIET; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS GROWTH; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFANT MORTALITY; INSULIN RELEASE; INSULIN TREATMENT; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL MORTALITY; MEDICATION COMPLIANCE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; SMALL FOR DATE INFANT; WOMEN'S HEALTH;

EID: 84904671027     PISSN: 09719202     EISSN: 09756434     Source Type: Journal    
DOI: 10.1007/s13224-014-0525-4     Document Type: Review

References (42)

1. Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy for 2013 for the IDF Diabetes Atlas. Diabetes Res Clin Pract. 2013;. doi: 10.1016/j.diabres.2013.11.003.
2. Pedersen J. Diabetes mellitus and pregnancy: present status of the hyperglycaemia-hyperinsulinism theory and the weight of the newborn baby. Postgrad Med J. 1971;(Suppl):66-67.
3. Magon N, Seshiah V. Gestational diabetes mellitus: noninsulin management. Indian J Endocr Metab. 2011;15:284-93.
4. Hernandez TL, Friedman JE, Van Pelt RE, et al. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34:1660-8.
5. Metzger BE, Lowe LP, Dyer AR, et al. HAPO study cooperative research group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002. (Pubitemid 351656454)
6. Crowther CA, Hiller JE, Moss JR, et al. Australian Carbohydrate Intolerance Study in pregnant women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-86.
7. Landon MB, Spong CY, Thom E, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339-48.
8. Langer O. Maternal glycemic criteria for insulin therapy in GDM. Diabetes Care. 1998;21(2):B91-8. (Pubitemid 28357039)
9. Diagnosis and Management of GDM: Indian Guidelines. Association of Physicians of India. Medicine Update 2013; Vol 13: Chapter 55.
10. Gestational diabetes mellitus. Practice Bulletin No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;122:406-16
11. Pertot T, Molyneaux L, Tan K, et al. Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus? Diabetes Care. 2011;34(10):2214-6.
12. Magon N, Chauhan M. Pregnancy in type 1 diabetes mellitus: how special are special issues? N Am J Med Sci. 2012;4:250-6.
13. Lambert K, Holt RI. The use of insulin analogues in pregnancy. Diabetes Obes Metab. 2013;15(10):888-900.
14. Durnwald CP. Insulin analogues in the treatment of gestational diabetes mellitus. Clin Obstet Gynecol. 2013;56(4):816-26.
15. Singh C, Jovanovic L. Insulin analogues in the treatment of diabetes in pregnancy. Obstet Gynecol Clin N Am. 2007;34:275-91. (Pubitemid 46891747)
16. Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30(4):771-6. (Pubitemid 46556565)
17. Zhou L, Fan L. Efficacy and safety of insulin aspart versus regular human insulin for women with gestational diabetes mellitus. Zhonghua Yi Xue Za Zhi. 2012;92(19):1334-6.
18. Heller S, Damm P, Mersebach H, et al. Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study. Diabetes Care. 2010;33(3):473-7.
19. Lloyd A, Townsend C, Munro V, et al. Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK. Curr Med Res Opin. 2009;25(3):599-605.
20. Hod M, Damm P, Kaaja R, et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008;98(2):186e.1-7.
21. Pettitt DJ, Ospina P, Howard C, et al. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabet Med. 2007;24(10):1129-35. (Pubitemid 47437887)
22. Di Cianni G, Torlone E, Lencioni C, et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med. 2008;25(8):993-6.
23. Pettitt DJ, Ospina P, Kolaczynski JW, et al. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care. 2003;26(1):183-6. (Pubitemid 36929014)
24. Lindholm A, Jensen LB, Home PD, et al. Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care. 2002;25(5):876-82. (Pubitemid 41094286)
25. Durnwald CP, Landon MB. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. J Matern Fetal Neonataled. 2008;21(5):309-13. (Pubitemid 351652520)
26. Colatrella A, Visalli N, Abbruzzese S, et al. Comparison of insulin lispro protamine suspension with NPH insulin in pregnant women with type 2 and gestational diabetes mellitus: maternal and perinatal outcomes. Int J Endocrinol. 2013; doi:10.1155/2013/151975.
27. Cypryk K, Sobczak M, Pertynska-Marczewska M, et al. Pregnancy complications and perinatal outcome in diabetic women treated with humalog (insulin lispro) or regular human insulin during pregnancy. Med Sci Monit. 2004;10(2):PI29-32. (Pubitemid 38233070)
28. Persson B, Swahn ML, Hjertberg R, et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res Clin Pract. 2002;58(2):115-21.
29. Bhattacharyya A, Brown S, Hughes S, et al. Insulin lispro and regular insulin in pregnancy. QJM. 2001;94:255-60. (Pubitemid 32492747)
30. Jovanovic L, Ilic S, Pettitt DJ, et al. The metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabet Care. 1999;22:1422-6.
31. Price N, Bartlett C, Gillmer M. Use of insulin glargine during pregnancy: a case-control pilot study. Br J Obstet Gynecol. 2007;114(4):453-7. (Pubitemid 46393280)
32. Lapolla A, Di Cianni G, Bruttomesso D, et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women. Diabet Med. 2009;26(11):1181-2.
33. Sciacca L, Marotta V, Insalaco F, et al. Use of insulin detemir during pregnancy. Nutr Metab Cardiovasc Dis. 2010;20(4):e15-6.
34. Hod M, Mathiesen ER, Jovanovič L, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med. 2014;27(1):7-13.
35. Callesen NF, Damm J, Mathiesen JM, et al. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. J Matern Fetal Neonatal Med. 2013;26(6):588-92.
36. Mathiesen ER, Hod M, Ivanisevic M, et al. Detemir in pregnancy study group maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35(10):2012-7.
37. Shenoy VV, Cook SJ, Parry AF, et al. Audit of insulin detemir in pregnancy: a retrospective case series. Diabet Med. 2012;29(7):958-9.
38. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patients compliance. Diabete Care. 1997;20:1512-7. (Pubitemid 27415025)
39. Balaji V, Balaji MS, Alexander C, et al. Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study. Gynecol Endocrinol. 2012;28(7):529-32.
40. Seshiah V, Balaji V. Insulin therapy during pregnancy. J Assoc Phys India. 2007;55(Suppl):44-6.
41. Magon N. Fetal origins of adult disease: the diabetic charkravyuh. AOGD Bulletin. 2013;13(3):11-4.
42. Magon N. Gestational diabetes mellitus: get, set, go. From diabetes capital of the world to diabetes care capital of the world. Indian J Endocr Metab. 2011;15:161-9.